Receive our newsletter – data, insights and analysis delivered to you
Sponsored by Powder Systems Limited (PSL)

Containment for Cytotoxic

Free White Paper

Containment for Cytotoxic

By Powder Systems Limited (PSL)

Containment for Cytotoxic

By Powder Systems Limited (PSL)
Enter your details to receive the free paper:

Today drug discoveries are leading to more effective potent drugs, which also require greater worker protection. Powder Systems Ltd (PSL) supported Helsinn Advanced Synthesis set-up such a facility for producing cytotoxics.

Helsinn Advanced Synthesis (HAS), located in Biasca, Switzerland, is the chemical manufacturing business unit of the Helsinn Group.

To meet the demand for anticancer molecules HAS opened a new cytotoxic facility this year. The plant comprises R&D and QC laboratories, a small-scale GMP area for the production of reduced quantities of cytotoxic active pharmaceutical ingredients (APIs) and two larger production areas for the production of cytotoxic product at commercial scale.

The facility is exclusively dedicated to the development, analysis and manufacturing of clinical and commercial cytotoxic APIs.

Download to find out more.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy